Shanghai Fosun Pharmaceutical (02196) completes issuance of 1 billion yuan of technology innovation bonds.

18:02 03/02/2026

Fosun Pharma (02196) announced that the company has recently completed the issuance of the first phase of technology innovation bonds for the year 2026. The bond is referred to as "26 Fosun Pharma MTN001 (Technology Innovation Bond)", with a total actual issuance amount of 1 billion RMB.

Shanghai Fosun Pharmaceutical (02196) announced that it has recently completed the issuance of the first phase of Technology Innovation Bonds for the year 2026. The bond is called "26 Shanghai Fosun Pharmaceutical MTN001 (Technology Innovation Bond)" with a total actual issuance amount of 1 billion yuan.

Contemporary Amperex Technology (03750) has repurchased a total of 15.99 million A shares by the end of January.

Desire to accelerate the mining of "urban mines" industry dividends through cross-shareholding strategic investment in ENVISION GREEN (01783), Tianqi Lithium Corporation (09696).

DYNASTY WINES (00828) appoints Zhao Haijing as an executive director

Contemporary Amperex Technology (03750) has repurchased a total of 15.99 million A shares by the end of January.

Desire to accelerate the mining of "urban mines" industry dividends through cross-shareholding strategic investment in ENVISION GREEN (01783), Tianqi Lithium Corporation (09696).

DYNASTY WINES (00828) appoints Zhao Haijing as an executive director